News

Featured Articles

Cristalia products with Nemera’s reusable pen injector commercialized in Brazil.

Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.

2021 Products

Symbioze won the Pharmapack Award 2021

30/09/2021

On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.

Safe'n'Sound 2.25ml: Robust and ergonomic design for user safety, suitable for biologic and high-value drugs

2021

Introducing our innovative Safe’n’Sound® in 2.25 mL size

05/06/2021

“Introducing our innovative Safe’n’Sound® in 2.25 mL size": premium add-on and highly customizable passive safety devices adapted to your complex injectable formulations. The platform is suitable for low fill ...

2021

Nemera cares about charity!

05/06/2021

Nemera cares about charity! Nemera employees have the opportunity to make a donation to charities. In July 2018, we started a collaboration with Microdon, a platform representing a great number...

2020

Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services!

05/06/2021

Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services! In August 2019, global drug delivery leader Nemera acquired top innovation services firm Insight Product Development. Today,...

2021

Safety week is back at Nemera!

20/09/2021

We are happy to announce the come back of our Safety Week, to give awareness to Nemera’s employees around health and safety at work

2021 Events

International Women’s Day 2021

06/04/2021

Celebrating our leaders, not with a rose, but with a voice. An equal world is an empowered world. At Nemera, each individual is unique with a unique story and we...